Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Kosiborod, Mikhail, Lam, Carolyn SP, Kohsaka, Shun, Kim, Dae Jung, Karasik, Avraham, Shaw, Jonathan, Tangri, Navdeep, Goh, Su-Yen, Thuresson, Marcus, Chen, Hungta
et al (show 58 more authors) (2018) Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study. Journal of the American College of Cardiology, 71 (23). 2628 - 2639.


Kosiborod, Mikhail, Birkeland, Kare I, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Jorgensen, Marit E, Wittbrodt, Eric T
et al (show 5 more authors) (2018) Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study. DIABETES OBESITY & METABOLISM, 20 (8). 1983 - 1987.


Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Thuresson, Marcus
et al (show 5 more authors) (2018) Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". CIRCULATION, 137 (9). 989 - 991.


Cavender, Matthew A, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Fu, Alex Z, Bodegard, Johan, Blak, Betina T, Wittbrodt, Eric
et al (show 5 more authors) (2018) SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71 (22). 2497 - 2506.

This list was generated on Mon Nov 23 09:51:46 2020 GMT.